Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 354 (9173) , 106-110
- https://doi.org/10.1016/s0140-6736(98)12494-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Evaluation of a New Point-of-care Test that Measures PAF-mediated Acceleration of Coagulation in Cardiac Surgical PatientsAnesthesiology, 1996
- The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgeryBlood Coagulation & Fibrinolysis, 1995
- 1‐deamino‐8‐D‐arginine vasopressin (DCAVP) increases platelet membrane expression of glycoprotein Ib in patients with disorders of platelet function and after cardiopulmonary bypassAmerican Journal of Hematology, 1994
- Significant hyponatremia following DDAVP administration in a healthy adultAmerican Journal of Hematology, 1993
- The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass SurgeryAnesthesiology, 1992
- DDAVP‐induced enhancement of platelet retention: Its dependence on platelet‐von Willebrand Factor and the platelet receptor GP IIb/IIIaEuropean Journal of Haematology, 1992
- A Trial of Desmopressin (1-Desamino-8-D-Arginine Vasopressin) to Reduce Blood Loss in Uncomplicated Cardiac SurgeryNew England Journal of Medicine, 1989
- DESMOPRESSIN AND MYOCARDIAL INFARCTIONThe Lancet, 1989
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986